Pharmacokinetics of Two Fatty Acid Ketone Esters

NCT05686083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-04-20

No results posted yet for this study

Summary

Randomized, cross over pharmacokinetic study of a novel ketone di-ester and C6 ketone di-ester in ready to drink beverage matrices.

Conditions

  • Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

C6 ketone di-ester

C6 ketone di-ester

DIETARY_SUPPLEMENT

Novel ketone di-ester

Novel ketone di-ester

Sponsors & Collaborators

  • Mérieux NutriSciences Biofortis

    collaborator UNKNOWN
  • BHB Therapeutics, Ireland LTD

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05686083 on ClinicalTrials.gov